Published in Proteomics on December 01, 2007
Mass spectrometric imaging for biomedical tissue analysis. Chem Rev (2010) 2.51
Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. Chem Rev (2013) 1.80
Multiple isotopic labels for quantitative mass spectrometry. Anal Chem (2008) 1.49
Novel endogenous peptide agonists of cannabinoid receptors. FASEB J (2009) 1.25
Development and evaluation of normalization methods for label-free relative quantification of endogenous peptides. Mol Cell Proteomics (2009) 1.18
Neuropeptidomics of the supraoptic rat nucleus. J Proteome Res (2008) 1.13
Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins. Mol Biosyst (2010) 1.05
Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney. Am J Physiol Endocrinol Metab (2012) 1.04
Quality assessment for clinical proteomics. Clin Biochem (2012) 0.98
Peptidomic analysis of human cell lines. J Proteome Res (2011) 0.96
Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J Biol Chem (2012) 0.96
Investigating endogenous peptides and peptidases using peptidomics. Biochemistry (2011) 0.91
Hemopressins and other hemoglobin-derived peptides in mouse brain: comparison between brain, blood, and heart peptidome and regulation in Cpefat/fat mice. J Neurochem (2010) 0.90
Probing neuropeptide signaling at the organ and cellular domains via imaging mass spectrometry. J Proteomics (2012) 0.88
Mass spectrometry imaging, an emerging technology in neuropsychopharmacology. Neuropsychopharmacology (2013) 0.87
Sample preparation techniques for the untargeted LC-MS-based discovery of peptides in complex biological matrices. J Biomed Biotechnol (2011) 0.87
Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease. Mol Cell Proteomics (2009) 0.87
From pixel to voxel: a deeper view of biological tissue by 3D mass spectral imaging. Bioanalysis (2011) 0.87
The impact of biosampling procedures on molecular data interpretation. Mol Cell Proteomics (2013) 0.87
Proteomic identification of immunoproteasome accumulation in formalin-fixed rodent spinal cords with experimental autoimmune encephalomyelitis. J Proteome Res (2012) 0.85
Impact of temperature dependent sampling procedures in proteomics and peptidomics--a characterization of the liver and pancreas post mortem degradome. Mol Cell Proteomics (2010) 0.84
Analysis of peptides secreted from cultured mouse brain tissue. Biochim Biophys Acta (2013) 0.81
Mass spectrometric analysis of spatio-temporal dynamics of crustacean neuropeptides. Biochim Biophys Acta (2014) 0.80
Neuropeptidomic analysis of the embryonic Japanese quail diencephalon. BMC Dev Biol (2010) 0.79
Mass spectrometric evaluation of neuropeptidomic profiles upon heat stabilization treatment of neuroendocrine tissues in crustaceans. J Proteome Res (2013) 0.79
The use of neuroproteomics in drug abuse research. Drug Alcohol Depend (2009) 0.77
Analysis of the Yeast Peptidome and Comparison with the Human Peptidome. PLoS One (2016) 0.75
Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med (2005) 5.89
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A (2004) 3.87
Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med (2003) 3.74
Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet (2013) 2.62
How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov (2007) 2.29
Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics (2013) 2.11
Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med (2010) 2.09
Adenosine and brain function. Int Rev Neurobiol (2005) 1.97
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature (2002) 1.91
Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins. Proc Natl Acad Sci U S A (2004) 1.86
S100A10 regulates plasminogen-dependent macrophage invasion. Blood (2010) 1.85
Depression in Parkinson disease--epidemiology, mechanisms and management. Nat Rev Neurol (2011) 1.69
Peptidomics-based discovery of novel neuropeptides. J Proteome Res (2003) 1.65
Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci (2008) 1.63
Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci (2009) 1.62
Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry. PLoS One (2010) 1.58
The Rho-specific GEF Lfc interacts with neurabin and spinophilin to regulate dendritic spine morphology. Neuron (2005) 1.57
Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior. Am J Psychiatry (2014) 1.54
Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine. Blood (2006) 1.49
Tardive dyskinesia model in the common marmoset. Mov Disord (2002) 1.44
Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis. J Exp Med (2003) 1.39
Beta1 integrin is not essential for hematopoiesis but is necessary for the T cell-dependent IgM antibody response. Immunity (2002) 1.38
SwePep, a database designed for endogenous peptides and mass spectrometry. Mol Cell Proteomics (2006) 1.32
Differential homing mechanisms regulate regionalized effector CD8alphabeta+ T cell accumulation within the small intestine. Proc Natl Acad Sci U S A (2007) 1.31
Heat stabilization of the tissue proteome: a new technology for improved proteomics. J Proteome Res (2009) 1.29
Critical role of FLT3 ligand in IL-7 receptor independent T lymphopoiesis and regulation of lymphoid-primed multipotent progenitors. Blood (2007) 1.28
The role of 5-HT(1A) receptors in learning and memory. Behav Brain Res (2008) 1.28
The role of DARPP-32 in the actions of drugs of abuse. Neuropharmacology (2004) 1.27
Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action. Neuropsychopharmacology (2006) 1.24
CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes. Eur J Immunol (2004) 1.24
EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease. Mov Disord (2014) 1.23
Functional characterization of the CCL25 promoter in small intestinal epithelial cells suggests a regulatory role for caudal-related homeobox (Cdx) transcription factors. J Immunol (2006) 1.21
Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biol Psychiatry (2010) 1.19
Development and evaluation of normalization methods for label-free relative quantification of endogenous peptides. Mol Cell Proteomics (2009) 1.18
Decreased striatal levels of PEP-19 following MPTP lesion in the mouse. J Proteome Res (2006) 1.17
Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. J Proteome Res (2004) 1.17
Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc Natl Acad Sci U S A (2004) 1.16
Binding mode of Thioflavin T in insulin amyloid fibrils. J Struct Biol (2007) 1.14
Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons. Proc Natl Acad Sci U S A (2013) 1.09
Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation. Neuropharmacology (2008) 1.08
Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J Neurosci (2005) 1.07
p11 and its role in depression and therapeutic responses to antidepressants. Nat Rev Neurosci (2013) 1.07
Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism. Proc Natl Acad Sci U S A (2008) 1.06
Involvement of CCL25 (TECK) in the generation of the murine small-intestinal CD8alpha alpha+CD3+ intraepithelial lymphocyte compartment. Eur J Immunol (2002) 1.05
Pharmacology of adenosine A2A receptors and therapeutic applications. Curr Top Med Chem (2003) 1.04
Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol (2011) 1.03
Novel mass spectrometry imaging software assisting labeled normalization and quantitation of drugs and neuropeptides directly in tissue sections. J Proteomics (2012) 1.03
A neuroproteomic approach to targeting neuropeptides in the brain. Proteomics (2002) 1.03
Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities. Neurology (2003) 1.00
Physiological role for casein kinase 1 in glutamatergic synaptic transmission. J Neurosci (2005) 1.00
A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biol Psychiatry (2010) 0.99
Serotonin-1A receptors in major depression quantified using PET: controversies, confounds, and recommendations. Neuroimage (2011) 0.99
5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. Eur J Pharmacol (2008) 0.99
Regulation of fibrinolysis by S100A10 in vivo. Blood (2011) 0.98
Co-expression of serotonin 5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum. Neuropharmacology (2011) 0.97
Mass spectrometry imaging in drug development. Anal Chem (2015) 0.96
Ligand-controlled assembly of hexamers, dihexamers, and linear multihexamer structures by the engineered acylated insulin degludec. Biochemistry (2013) 0.96
Neuropeptidomics strategies for specific and sensitive identification of endogenous peptides. Mol Cell Proteomics (2007) 0.96
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo. J Pharmacol Exp Ther (2007) 0.94
Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels. Mol Pharmacol (2010) 0.94
Developments in biobanking workflow standardization providing sample integrity and stability. J Proteomics (2013) 0.94
Neurotoxin-induced neuropeptide perturbations in striatum of neonatal rats. J Proteome Res (2013) 0.93
Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. Neurosci Lett (2013) 0.92
Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression. J Neurol (2009) 0.91
Altered extracellular striatal in vivo biotransformation of the opioid neuropeptide dynorphin A(1-17) in the unilateral 6-OHDA rat model of Parkinson's disease. J Mass Spectrom (2005) 0.91
Rapid dendritic cell mobilization to the large intestinal epithelium is associated with resistance to Trichuris muris infection. J Immunol (2009) 0.91
Neuropeptidomics: MS applied to the discovery of novel peptides from the brain. Anal Chem (2007) 0.90
Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA). J Neurosci (2011) 0.89
Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model. Physiol Behav (2007) 0.89
Mass spectrometry imaging, an emerging technology in neuropsychopharmacology. Neuropsychopharmacology (2013) 0.87
Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure. PLoS One (2008) 0.87
Proteomic profiling of the Baltic Sea cyanobacterium Nodularia spumigena strain AV1 during ammonium supplementation. J Proteomics (2010) 0.87
Deuterated matrix-assisted laser desorption ionization matrix uncovers masked mass spectrometry imaging signals of small molecules. Anal Chem (2012) 0.87
Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease. Mol Cell Proteomics (2009) 0.87
De novo mutations in ataxin-2 gene and ALS risk. PLoS One (2013) 0.86
(11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain. J Nucl Med (2014) 0.86
Electrokinetic-driven microfluidic system in poly(dimethylsiloxane) for mass spectrometry detection integrating sample injection, capillary electrophoresis, and electrospray emitter on-chip. Electrophoresis (2005) 0.86
MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra. J Parkinsons Dis (2012) 0.86
An automated method for scanning LC-MS data sets for significant peptides and proteins, including quantitative profiling and interactive confirmation. J Proteome Res (2007) 0.86
Conductive carbon tape used for support and mounting of both whole animal and fragile heat-treated tissue sections for MALDI MS imaging and quantitation. J Proteomics (2012) 0.86
Poly(dimethylsiloxane)-based microchip for two-dimensional solid-phase extraction-capillary electrophoresis with an integrated electrospray emitter tip. Anal Chem (2005) 0.85
Protection of stress-induced impairment of hippocampal/prefrontal LTP through blockade of glucocorticoid receptors: implication of MEK signaling. Exp Neurol (2008) 0.85
Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain. Neuropharmacology (2006) 0.85
Exposure to brominated flame retardant PBDE-99 affects cytoskeletal protein expression in the neonatal mouse cerebral cortex. Neurotoxicology (2008) 0.85
DARPP-32 involvement in the photic pathway of the circadian system. J Neurosci (2006) 0.84
Normalization and expression changes in predefined sets of proteins using 2D gel electrophoresis: a proteomic study of L-DOPA induced dyskinesia in an animal model of Parkinson's disease using DIGE. BMC Bioinformatics (2006) 0.84
Going forward: Increasing the accessibility of imaging mass spectrometry. J Proteomics (2012) 0.84
Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. J Neurochem (2003) 0.84